Scheduling, administration, biomarkers, and practical guidance.
Two distinct use cases with different protocols
Safe-default starting protocol
Advanced biphasic protocol
Short intensive cycle for specific repair targets
Well-established dermal application
Prevents receptor desensitization; non-negotiable for injectable use